论文部分内容阅读
目的观察脑卒中后吞咽障碍患者应用吞咽治疗仪治疗吸入性肺炎的疗效。方法 121例脑卒中后吞咽障碍患者随机分为治疗组和对照组,治疗组(60例)接受神经内科常规治疗基础上采用Vitalstim Master吞咽治疗仪经皮电刺激展开治疗,对照组(61例)接受神经内科常规治疗,1个月后分别观察两组患者肺炎的发生率。结果治疗组治疗有效率显著高于对照组,差异具有统计学意义(P<0.05);吸入性肺炎发生率显著低于对照组(P<0.01)。结论吞咽治疗仪可显著改善脑卒中后吞咽障碍患者吞咽功能,从而降低吸入性肺炎的发生率,临床可积极推广使用。
Objective To observe the therapeutic effect of swallowing therapeutic apparatus on aspiration pneumonia in patients with dysphagia after stroke. Methods Totally 121 patients with dysphagia after stroke were randomly divided into treatment group and control group. The treatment group (60 cases) received conventional neurology treatment and Vitalstim Master swallowing apparatus was used for percutaneous electrical stimulation. The control group (61 cases) Received routine treatment of neurology, one month later were observed in two groups of patients with pneumonia incidence. Results The effective rate of treatment group was significantly higher than that of control group, the difference was statistically significant (P <0.05); the incidence of aspiration pneumonia was significantly lower than that of control group (P <0.01). Conclusion Swallowing therapeutic apparatus can significantly improve the swallowing function of swallowing patients after stroke, so as to reduce the incidence of aspiration pneumonia. The clinical application can be actively promoted.